Download PDF
J Pediatr Genet 2018; 07(01): 001-008
DOI: 10.1055/s-0037-1617454
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics

John D. Gettelfinger
1   Department of Otolaryngology – Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States
,
John P. Dahl
1   Department of Otolaryngology – Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States
› Author Affiliations Funding None.
Further Information

Publication History

21 September 2017

29 November 2017

Publication Date:
04 January 2018 (online)

    Permissions and Reprints

Abstract

Congenital hearing loss is one of the most common birth defects worldwide, with around 1 in 500 people experiencing some form of severe hearing loss. While over 400 different syndromes involving hearing loss have been described, it is important to be familiar with a wide range of syndromes involving hearing loss so an early diagnosis can be made and early intervention can be pursued to maximize functional hearing and speech-language development in the setting of verbal communication. This review aims to describe the presentation and genetics for some of the most frequently occurring syndromes involving hearing loss, including neurofibromatosis type 2, branchio-oto-renal syndrome, Treacher Collins syndrome, Stickler syndrome, Waardenburg syndrome, Pendred syndrome, Jervell and Lange-Nielsen syndrome, Usher syndromes, Refsum disease, Alport syndrome, MELAS, and MERRF.

Keywords

hearing loss - syndromic - sensorineural
 

  • References

  • 1 Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 1991; 630 (01) 16-31
    CrossrefPubMedGoogle Scholar
  • 2 Smith RJ, Bale Jr JF, White KR. Sensorineural hearing loss in children. Lancet 2005; 365 (9462): 879-890
    CrossrefPubMedGoogle Scholar
  • 3 Li XC, Friedman RA. Nonsyndromic hereditary hearing loss. Otolaryngol Clin North Am 2002; 35 (02) 275-285
    CrossrefPubMedGoogle Scholar
  • 4 Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin North Am 2015; 48 (03) 443-460
    CrossrefPubMedGoogle Scholar
  • 5 Strasnick B, Glasscock III MEI, Haynes D, McMenomey SO, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope 1994; 104 (09) 1115-1119
    CrossrefPubMedGoogle Scholar
  • 6 Briggs RJ, Brackmann DE, Baser ME, Hitselberger WE. Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 1994; 120 (12) 1307-1314
    CrossrefPubMedGoogle Scholar
  • 7 Asthagiri AR, Parry DM, Butman JA. , et al. Neurofibromatosis type 2. Lancet 2009; 373 (9679): 1974-1986
    CrossrefPubMedGoogle Scholar
  • 8 Rouleau GA, Merel P, Lutchman M. , et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363 (6429): 515-521
    CrossrefPubMedGoogle Scholar
  • 9 Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol 2002; 22 (04) 1150-1157
    CrossrefPubMedGoogle Scholar
  • 10 Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang L-S. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002; 23 (05) 736-748
    CrossrefPubMedGoogle Scholar
  • 11 Kalatzis V, Petit C. Branchio-Oto-Renal syndrome. Adv Otorhinolaryngol 2000; 56: 39-44
    PubMedGoogle Scholar
  • 12 Chen A, Francis M, Ni L. , et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995; 58 (04) 365-370
    CrossrefPubMedGoogle Scholar
  • 13 Smith RJH, Schwartz C. Branchio-oto-renal syndrome. J Commun Disord 1998; 31 (05) 411-420 , quiz 421
    CrossrefPubMedGoogle Scholar
  • 14 Ceruti S, Stinckens C, Cremers CW, Casselman JW. Temporal bone anomalies in the branchio-oto-renal syndrome: detailed computed tomographic and magnetic resonance imaging findings. Otol Neurotol 2002; 23 (02) 200-207
    CrossrefPubMedGoogle Scholar
  • 15 Fraser FC, Sproule JR, Halal F, Optiz JM. Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980; 7 (03) 341-349
    CrossrefPubMedGoogle Scholar
  • 16 Abdelhak S, Kalatzis V, Heilig R. , et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997; 15 (02) 157-164
    CrossrefPubMedGoogle Scholar
  • 17 Kalatzis V, Abdelhak S, Compain S, Vincent C, Petit C. Characterization of a translocation-associated deletion defines the candidate region for the gene responsible for branchio-oto-renal syndrome. Genomics 1996; 34 (03) 422-425
    CrossrefPubMedGoogle Scholar
  • 18 Ruf RG, Xu PX, Silvius D. , et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci U S A 2004; 101 (21) 8090-8095
    CrossrefPubMedGoogle Scholar
  • 19 Hoskins BE, Cramer CH, Silvius D. , et al. Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet 2007; 80 (04) 800-804
    CrossrefPubMedGoogle Scholar
  • 20 Tadjuidje E, Hegde RS. The EYES absent proteins in development and disease. Cell Mol Life Sci 2013; 70 (11) 1897-1913
    CrossrefPubMedGoogle Scholar
  • 21 Trainor PA, Dixon J, Dixon MJ. Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur J Hum Genet 2009; 17 (03) 275-283
    CrossrefPubMedGoogle Scholar
  • 22 Stovin JJ, Lyon Jr JA, Clemmens RL. Mandibulofacial dysostosis. Radiology 1960; 74 (02) 225-231
    CrossrefPubMedGoogle Scholar
  • 23 Phelps PD, Poswillo D, Lloyd GA. The ear deformities in mandibulofacial dysostosis (Treacher Collins syndrome). Clin Otolaryngol Allied Sci 1981; 6 (01) 15-28
    CrossrefPubMedGoogle Scholar
  • 24 Dixon J, Edwards SJ, Gladwin AJ. et al; The Treacher Collins Syndrome Collaborative Group. Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. Nat Genet 1996; 12 (02) 130-136
    CrossrefPubMedGoogle Scholar
  • 25 Fazen LE, Elmore J, Nadler HL. Mandibulo-facial dysostosis. (Treacher-Collins syndrome). Am J Dis Child 1967; 113 (04) 405-410
    CrossrefPubMedGoogle Scholar
  • 26 Rovin S, Dachi SF, Borenstein DB, Cotter WB. Mandibulofacial dysostosis, a familial study of five generations. J Pediatr 1964; 65: 215-221
    CrossrefPubMedGoogle Scholar
  • 27 Dauwerse JG, Dixon J, Seland S. , et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011; 43 (01) 20-22
    CrossrefPubMedGoogle Scholar
  • 28 Kadakia S, Helman SN, Badhey AK, Saman M, Ducic Y. Treacher Collins syndrome: the genetics of a craniofacial disease. Int J Pediatr Otorhinolaryngol 2014; 78 (06) 893-898
    CrossrefPubMedGoogle Scholar
  • 29 Snead MP, Yates JRW. Clinical and molecular genetics of Stickler syndrome. J Med Genet 1999; 36 (05) 353-359
    PubMedGoogle Scholar
  • 30 Stickler GB, Hughes W, Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): a survey. Genet Med 2001; 3 (03) 192-196
    CrossrefPubMedGoogle Scholar
  • 31 Weingeist TA, Hermsen V, Hanson JW, Bumsted RM, Weinstein SL, Olin WH. Ocular and systemic manifestations of Stickler's syndrome: a preliminary report. Birth Defects Orig Artic Ser 1982; 18 (06) 539-560
    PubMedGoogle Scholar
  • 32 Nowak CB. Genetics and hearing loss: a review of Stickler syndrome. J Commun Disord 1998; 31 (05) 437-453 ; 453–454
    CrossrefPubMedGoogle Scholar
  • 33 Webb AC, Markus AF. The diagnosis and consequences of Stickler syndrome. Br J Oral Maxillofac Surg 2002; 40 (01) 49-51
    CrossrefPubMedGoogle Scholar
  • 34 Opitz JM, France T, Herrmann J, Spranger JW. The Stickler syndrome. N Engl J Med 1972; 286 (10) 546-547
    CrossrefPubMedGoogle Scholar
  • 35 Jacobson J, Jacobson C, Gibson W. Hearing loss in Stickler's syndrome: a family case study. J Am Acad Audiol 1990; 1 (01) 37-40
    PubMedGoogle Scholar
  • 36 Lucarini JW, Liberfarb RM, Eavey RD. Otolaryngological manifestations of the Stickler syndrome. Int J Pediatr Otorhinolaryngol 1987; 14 (2-3): 215-222
    CrossrefPubMedGoogle Scholar
  • 37 Helfgott SM, Mosciscki RA, San Martin J. , et al. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet 1991; 337 (8738): 387-389
    CrossrefPubMedGoogle Scholar
  • 38 Ahmad NN, Ala-Kokko L, Knowlton RG. , et al. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci U S A 1991; 88 (15) 6624-6627
    CrossrefPubMedGoogle Scholar
  • 39 Richards AJ, Yates JR, Williams R. , et al. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen. Hum Mol Genet 1996; 5 (09) 1339-1343
    CrossrefPubMedGoogle Scholar
  • 40 Vikkula M, Mariman EC, Lui VC. , et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 1995; 80 (03) 431-437
    CrossrefPubMedGoogle Scholar
  • 41 Acke FR, Dhooge IJ, Malfait F, De Leenheer EM. Hearing impairment in Stickler syndrome: a systematic review. Orphanet J Rare Dis 2012; 7: 84 . doi: 10.1186/1750-1172-7-84
    CrossrefPubMedGoogle Scholar
  • 42 Van Camp G, Snoeckx RL, Hilgert N. , et al. A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. Am J Hum Genet 2006; 79 (03) 449-457
    CrossrefPubMedGoogle Scholar
  • 43 Baker S, Booth C, Fillman C. , et al. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome. Am J Med Genet A 2011; 155A (07) 1668-1672
    PubMedGoogle Scholar
  • 44 Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows and noseroot with pigmentary anomalies of the iris and head hair and with congenital deafness; Dystopia canthi medialis et punctorum lacrimalium lateroversa, hyperplasia supercilii medialis et radicis nasi, heterochromia iridum totaliis sive partialis, albinismus circumscriptus (leucismus, polioss) et surditas congenita (surdimutitas). Am J Hum Genet 1951; 3 (03) 195-253
    PubMedGoogle Scholar
  • 45 Read AP, Newton VE. Waardenburg syndrome. J Med Genet 1997; 34 (08) 656-665
    CrossrefPubMedGoogle Scholar
  • 46 Nayak CS, Isaacson G. Worldwide distribution of Waardenburg syndrome. Ann Otol Rhinol Laryngol 2003; 112 (9 Pt 1): 817-820
    CrossrefPubMedGoogle Scholar
  • 47 Cremers CWRJ, Smith RJH. , eds. Genetic Hearing Impairment: Its Clinical Presentations. Basel; New York: Karger; 2002
    Google Scholar
  • 48 Liu XZ, Newton VE, Read AP. Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet 1995; 55 (01) 95-100
    CrossrefPubMedGoogle Scholar
  • 49 Hoth CF, Milunsky A, Lipsky N, Sheffer R, Clarren SK, Baldwin CT. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am J Hum Genet 1993; 52 (03) 455-462
    PubMedGoogle Scholar
  • 50 Shah KN, Dalal SJ, Desai MP, Sheth PN, Joshi NC, Ambani LM. White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome. J Pediatr 1981; 99 (03) 432-435
    CrossrefPubMedGoogle Scholar
  • 51 Zaman A, Capper R, Baddoo W. Waardenburg syndrome: more common than you think!. Clin Otolaryngol 2015; 40 (01) 44-48
    CrossrefPubMedGoogle Scholar
  • 52 Tassabehji M, Read AP, Newton VE. , et al. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992; 355 (6361): 635-636
    CrossrefPubMedGoogle Scholar
  • 53 Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, Read AP, Sánchez-García I. SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet 2002; 11 (25) 3231-3236
    CrossrefPubMedGoogle Scholar
  • 54 Wenzhi H, Ruijin W, Jieliang L. , et al. Heterozygous deletion at the SOX10 gene locus in two patients from a Chinese family with Waardenburg syndrome type II. Int J Pediatr Otorhinolaryngol 2015; 79 (10) 1718-1721
    CrossrefPubMedGoogle Scholar
  • 55 Attié T, Till M, Pelet A. , et al. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet 1995; 4 (12) 2407-2409
    CrossrefPubMedGoogle Scholar
  • 56 Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994; 8 (03) 251-255
    CrossrefPubMedGoogle Scholar
  • 57 Bondurand N, Dastot-Le Moal F, Stanchina L. , et al. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet 2007; 81 (06) 1169-1185
    CrossrefPubMedGoogle Scholar
  • 58 Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid 1999; 9 (01) 65-69
    CrossrefPubMedGoogle Scholar
  • 59 Morgans ME, Trotter WR. Association of congenital deafness with goitre; the nature of the thyroid defect. Lancet 1958; 1 (7021): 607-609
    PubMedGoogle Scholar
  • 60 Pendred V. Deaf-mutism and goitre. Lancet 1896; 148 (3808): 532
    PubMedGoogle Scholar
  • 61 Fugazzola L, Mannavola D, Cerutti N. , et al. Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J Clin Endocrinol Metab 2000; 85 (07) 2469-2475
    PubMedGoogle Scholar
  • 62 Reardon W, Coffey R, Phelps PD. , et al. Pendred syndrome–100 years of underascertainment?. QJM 1997; 90 (07) 443-447
    CrossrefPubMedGoogle Scholar
  • 63 Fraser GR. Association of congenital deafness with goitre (Pendred's syndrome): a study of 207 families. Ann Hum Genet 1965; 28 (1–3): 201-249
    PubMedGoogle Scholar
  • 64 Bizhanova A, Kopp P. Genetics and phenomics of Pendred syndrome. Mol Cell Endocrinol 2010; 322 (1–2): 83-90
    CrossrefPubMedGoogle Scholar
  • 65 Everett LA, Glaser B, Beck JC. , et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997; 17 (04) 411-422
    CrossrefPubMedGoogle Scholar
  • 66 Pera A, Villamar M, Viñuela A. , et al. A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. Eur J Hum Genet 2008; 16 (08) 888-896
    CrossrefPubMedGoogle Scholar
  • 67 Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957; 54 (01) 59-68
    CrossrefPubMedGoogle Scholar
  • 68 Komsuoğlu B, Göldeli O, Kulan K. , et al. The Jervell and Lange-Nielsen syndrome. Int J Cardiol 1994; 47 (02) 189-192
    CrossrefPubMedGoogle Scholar
  • 69 Neyroud N, Tesson F, Denjoy I. , et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997; 15 (02) 186-189
    CrossrefPubMedGoogle Scholar
  • 70 Tyson J, Tranebjaerg L, Bellman S. , et al. IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997; 6 (12) 2179-2185
    CrossrefPubMedGoogle Scholar
  • 71 Schulze-Bahr E, Wang Q, Wedekind H. , et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17 (03) 267-268
    CrossrefPubMedGoogle Scholar
  • 72 Öcal B, Imamoglu A, Atalay S, Ercan Tutar H. Prevalence of idiopathic long QT syndrome in children with congenital deafness. Pediatr Cardiol 1997; 18 (06) 401-405
    CrossrefPubMedGoogle Scholar
  • 73 Keats BJ, Corey DP. The Usher syndromes. Am J Med Genet 1999; 89 (03) 158-166
    CrossrefPubMedGoogle Scholar
  • 74 Petit C. Usher syndrome: from genetics to pathogenesis. Annu Rev Genomics Hum Genet 2001; 2 (01) 271-297
    CrossrefPubMedGoogle Scholar
  • 75 Smith RJ, Berlin CI, Hejtmancik JF. , et al; Usher Syndrome Consortium. Clinical diagnosis of the Usher syndromes. Am J Med Genet 1994; 50 (01) 32-38
    CrossrefPubMedGoogle Scholar
  • 76 Gorlin RJ, Tilsner TJ, Feinstein S, Duvall III AJ. Usher's syndrome type III. Arch Otolaryngol 1979; 105 (06) 353-354
    CrossrefPubMedGoogle Scholar
  • 77 Auffarth GU, Tetz MR, Krastel H, Blankenagel A, Völcker HE. Complicated cataracts in various forms of retinitis pigmentosa. Type and incidence [in German]. Ophthalmologe 1997; 94 (09) 642-646
    CrossrefPubMedGoogle Scholar
  • 78 Pennings RJE, Wagenaar M, van Aarem A, Huygen PLM, Kimberling WJ, Cremers CWRJ. Hearing Impairment in Usher's Syndrome. Vol. 61. Karger Publishers; 2002:184_191. Available at: http://www.karger.com/Article/Abstract/66832 . Accessed February 8, 2017
    PubMedGoogle Scholar
  • 79 Weil D, Blanchard S, Kaplan J. , et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995; 374 (6517): 60-61
    CrossrefPubMedGoogle Scholar
  • 80 Ko MK, Kenderling WJ, Friedman RA. Genetics of ear disorders. In: Cummings Otolaryngology. 6th ed. Elsevier; 2015: 2275-2284
    Google Scholar
  • 81 Eudy JD, Weston MD, Yao S. , et al. Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science 1998; 280 (5370): 1753-1757
    CrossrefPubMedGoogle Scholar
  • 82 Weston MD, Eudy JD, Fujita S. , et al. Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet 2000; 66 (04) 1199-1210
    CrossrefPubMedGoogle Scholar
  • 83 Boughman JA, Vernon M, Shaver KA. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J Chronic Dis 1983; 36 (08) 595-603
    CrossrefPubMedGoogle Scholar
  • 84 Kimberling WJ, Hildebrand MS, Shearer AE. , et al. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med 2010; 12 (08) 512-516
    CrossrefPubMedGoogle Scholar
  • 85 Davies MG, Marks R, Dykes PJ, Reynolds D. Epidermal abnormalities in Refsum's disease. Br J Dermatol 1977; 97 (04) 401-406
    CrossrefPubMedGoogle Scholar
  • 86 Jansen GA, Ofman R, Ferdinandusse S. , et al. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 1997; 17 (02) 190-193
    CrossrefPubMedGoogle Scholar
  • 87 van den Brink DM, Brites P, Haasjes J. , et al. Identification of PEX7 as the second gene involved in Refsum disease. Am J Hum Genet 2003; 72 (02) 471-477
    CrossrefPubMedGoogle Scholar
  • 88 Steinberg D. The metabolic basis of the Refsum syndrome. Birth Defects Orig Artic Ser 1971; 7 (01) 42-52
    PubMedGoogle Scholar
  • 89 Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identification of PAHX, a Refsum disease gene. Nat Genet 1997; 17 (02) 185-189
    CrossrefPubMedGoogle Scholar
  • 90 Wanders RJA, Waterham HR, Leroy BP. Refsum disease. In: Pagon RA, Adam MP, Ardinger HH. , et al, eds. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993. . Available at: http://www.ncbi.nlm.nih.gov/books/NBK1353/ . Accessed February 11, 2017
    Google Scholar
  • 91 Alport AC. Hereditary familial congenital haemorrhagic nephritis. BMJ 1927; 1 (3454): 504-506
    CrossrefPubMedGoogle Scholar
  • 92 Fallerini C, Dosa L, Tita R. , et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet 2014; 86 (03) 252-257
    CrossrefPubMedGoogle Scholar
  • 93 Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet 1988; 2 (8618): 1005-1007
    PubMedGoogle Scholar
  • 94 Plant KE, Green PM, Vetrie D, Flinter FA. Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 1999; 13 (02) 124-132
    CrossrefPubMedGoogle Scholar
  • 95 Streeten BW, Robinson MR, Wallace R, Jones DB. Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 1987; 105 (12) 1693-1697
    CrossrefPubMedGoogle Scholar
  • 96 Kashtan C. Alport syndrome: facts and opinions. F1000 Res 2017; 6: 50
    CrossrefPubMedGoogle Scholar
  • 97 Merchant SN, Burgess BJ, Adams JC. , et al. Temporal bone histopathology in Alport syndrome. Laryngoscope 2004; 114 (09) 1609-1618
    CrossrefPubMedGoogle Scholar
  • 98 Hashimura Y, Nozu K, Kaito H. , et al. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 2014; 85 (05) 1208-1213
    CrossrefPubMedGoogle Scholar
  • 99 Plevová P, Gut J, Janda J. Familial hematuria: a review. Medicina (Kaunas) 2017; 53 (01) 1-10
    CrossrefPubMedGoogle Scholar
  • 100 Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58 (03) 925-943
    CrossrefPubMedGoogle Scholar
  • 101 Barker DF, Hostikka SL, Zhou J. , et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248 (4960): 1224-1227
    CrossrefPubMedGoogle Scholar
  • 102 Morinière V, Dahan K, Hilbert P. , et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 2014; 25 (12) 2740-2751
    CrossrefPubMedGoogle Scholar
  • 103 Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16 (04) 481-488
    CrossrefPubMedGoogle Scholar
  • 104 Ensink RJ, Camp GV, Cremers CW. Mitochondrial inherited hearing loss. Clin Otolaryngol Allied Sci 1998; 23 (01) 3-8
    CrossrefPubMedGoogle Scholar
  • 105 Nadol Jr JB, Merchant SN. Histopathology and molecular genetics of hearing loss in the human. Int J Pediatr Otorhinolaryngol 2001; 61 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 106 Zwirner P, Wilichowski E. Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 2001; 111 (03) 515-521
    CrossrefPubMedGoogle Scholar
  • 107 Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348 (6302): 651-653
    CrossrefPubMedGoogle Scholar
  • 108 Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990; 61 (06) 931-937
    CrossrefPubMedGoogle Scholar
  • 109 Wallace DC, Zheng XX, Lott MT. , et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988; 55 (04) 601-610
    CrossrefPubMedGoogle Scholar